Cite
HARVARD Citation
Chang, S. et al. (2022). 14‐day reverse hybrid therapy vs 7‐day concomitant therapy in the first‐line treatment of Helicobacter pylori infection. Advances in digestive medicine. 9 (1), pp. 38-43. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chang, S. et al. (2022). 14‐day reverse hybrid therapy vs 7‐day concomitant therapy in the first‐line treatment of Helicobacter pylori infection. Advances in digestive medicine. 9 (1), pp. 38-43. [Online].